Detalhe da pesquisa
1.
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry.
Retrovirology
; 8: 89, 2011 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22054077